Representativeness in Premarketing vs Postmarketing US Food and Drug Administration Trials

被引：1
|
作者：
Unger, Joseph M. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M3-C102,POB 19024, Seattle, WA 98109 USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2021.7159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] US food and drug administration
    Goodman, Jesse
    ONCOLOGY-NEW YORK, 2006, 20 (08): : 946 - 946
  • [22] US Food and Drug Administration
    Blumenthal, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S37 - S37
  • [23] Improving the Food and Drug Administration's Mandate to Ensure Postmarketing Drug Safety
    Qato, Dima M.
    Alexander, G. Caleb
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (14): : 1595 - 1596
  • [24] The US Food and Drug Administration's Efforts to Support Ophthalmology Clinical Trials
    Eydelman, Malvina B.
    JAMA OPHTHALMOLOGY, 2014, 132 (12) : 1391 - 1392
  • [25] US Food and Drug Administration defends use of placebo-controlled trials
    Larkin, M
    LANCET, 2000, 356 (9235): : 1086 - 1086
  • [26] Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug Administration
    Green, Dionna J.
    Liu, Xiaomei I.
    Hua, Tianyi
    Burnham, Janelle M.
    Schuck, Robert
    Pacanowski, Michael
    Yao, Lynne
    McCune, Susan K.
    Burckart, Gilbert J.
    Zineh, Issam
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 983 - 988
  • [27] Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
    Wallach, Joshua D.
    Luxkaranayagam, Anita T.
    Dhruva, Sanket S.
    Miller, Jennifer E.
    Ross, Joseph S.
    BMC MEDICINE, 2019, 17 (1)
  • [28] Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
    Fan, Min
    Chan, Adrienne Y. L.
    Yan, Vincent K. C.
    Tong, Xinning
    Lau, Lauren K. W.
    Wan, Eric Y. F.
    Tam, Eliza Y. T.
    Ip, Patrick
    Lum, Terry Y.
    Wong, Ian C. K.
    Li, X.
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [29] Postmarketing safety of orphan drugs: A longitudinal analysis of US Food and Drug Administration database between 2006 and 2015
    Chan, Adrienne Y. L.
    Fan, Min
    Yan, Vincent K. C.
    Tam, Eliza Y. T.
    Chan, Esther W.
    Wong, Ian C. K.
    Li, Xue
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 564 - 564
  • [30] Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
    Min Fan
    Adrienne Y. L. Chan
    Vincent K. C. Yan
    Xinning Tong
    Lauren K. W. Lau
    Eric Y. F. Wan
    Eliza Y. T. Tam
    Patrick Ip
    Terry Y. Lum
    Ian C. K. Wong
    X. Li
    Orphanet Journal of Rare Diseases, 17
12345